Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference
LONDON, May 23, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or…
Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership